CARGO Therapeutics, Inc. (CRGX)
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
Address
835 INDUSTRIAL ROAD, SUITE 400
SAN CARLOS, CA 94070
Founded
2019
Number of Employees
-
Website
http://cargo-tx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)